|
gptkbp:instanceOf
|
gptkb:chemical_compound
recreational drug
dissociative drug
|
|
gptkbp:abusePotential
|
high
|
|
gptkbp:CASNumber
|
1239943-76-0
|
|
gptkbp:category
|
gptkb:arylcyclohexylamine
NMDA receptor antagonist
dissociative anesthetic
|
|
gptkbp:chemicalFormula
|
C15H21NO2
|
|
gptkbp:developedBy
|
recreational drug
|
|
gptkbp:discoveredBy
|
2010s
|
|
gptkbp:eliminationHalfLife
|
3-6 hours
|
|
gptkbp:excretion
|
renal
|
|
gptkbp:firstReported
|
2010
|
|
gptkbp:hasStreet
|
gptkb:MXE
gptkb:roflcoptr
mexxy
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
methoxetamine
|
|
gptkbp:IUPACName
|
gptkb:2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone
|
|
gptkbp:legalStatus
|
gptkb:Schedule_I_in_United_States
illegal in Germany
illegal in Canada
illegal in China
illegal in United Kingdom
|
|
gptkbp:mechanismOfAction
|
NMDA receptor antagonist
|
|
gptkbp:metabolism
|
hepatic
|
|
gptkbp:molecularWeight
|
247.33 g/mol
|
|
gptkbp:not_approved_for_medical_use
|
true
|
|
gptkbp:PubChem_CID
|
2105717
29342082
57427945
|
|
gptkbp:relatedTo
|
gptkb:ketamine
gptkb:phencyclidine
|
|
gptkbp:routeOfAdministration
|
oral
insufflation
intramuscular injection
|
|
gptkbp:sideEffect
|
nausea
dissociation
tachycardia
hallucinations
urinary tract toxicity
|
|
gptkbp:toxicity
|
psychosis
seizures
death (in overdose)
bladder damage
|
|
gptkbp:UNII
|
6P7W6C086B
|
|
gptkbp:bfsParent
|
gptkb:PCP
gptkb:Para-Methoxy_Ketamine
|
|
gptkbp:bfsLayer
|
6
|